These limitations in the BTNX NTS are highly suitable, as we discovered e.g. etodesnitazene to obtain the same in vitro potency and efficacy as fentanyl [seven, 13] and as it may well most likely give PWUD a false perception of security. Also, the detectability of nitazene analogues in drug samples may be impacted by solubility challenges, as highl